Breaking News Instant updates and real-time market news.

2020-12-08 04:55:00 PLOW Douglas Dynamics $41.14 / +0.195 (+0.48%) 04:55 12/08/20 12/08 04:55 12/08/20 04:55	Douglas Dynamics participates in a conference call with Craig-Hallum Conference call with management will be held on December 8 hosted by Craig-Hallum.	08 Dec
PLOW Douglas Dynamics $41.14 / +0.195 (+0.48%) 04/21/20 Craig-Hallum Douglas Dynamics price target lowered to $40 from $55 at Craig-Hallum 03/12/20 Sidoti Douglas Dynamics upgraded to Buy from Neutral at Sidoti 02/26/20 Craig-Hallum Douglas Dynamics downgraded to Hold from Buy at Craig-Hallum 01/14/20 Sidoti Douglas Dynamics downgraded to Neutral from Buy at Sidoti

2020-12-08 04:55:00

PLOW

Douglas Dynamics

$41.14 / +0.195 (+0.48%)

04:55

12/08/20

12/08

04:55

12/08/20

04:55

Douglas Dynamics participates in a conference call with Craig-Hallum

Conference call with management will be held on December 8 hosted by Craig-Hallum.

08
Dec

PLOW Douglas Dynamics

$41.14 / +0.195 (+0.48%)

04/21/20 Craig-Hallum: Douglas Dynamics price target lowered to $40 from $55 at Craig-Hallum

03/12/20 Sidoti: Douglas Dynamics upgraded to Buy from Neutral at Sidoti

02/26/20 Craig-Hallum: Douglas Dynamics downgraded to Hold from Buy at Craig-Hallum

01/14/20 Sidoti: Douglas Dynamics downgraded to Neutral from Buy at Sidoti

TODAY'S FREE FLY STORIES

Initiation	Nippon Telegraph initiated with a Buy at Goldman Sachs » 14:02 01/22/21 01/22 14:02 01/22/21 14:02 NTTYY Nippon Telegraph $0.00 / + (+0.00%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Periodicals Events NTTYY Nippon Telegraph $0.00 / + (+0.00%) 10/12/20 Citi Nippon Telegraph downgraded to Neutral from Buy at Citi NTTYY Nippon Telegraph $0.00 / + (+0.00%) 09/29/20 Nippon Telegraph plans to take over Docomo for $38B, Nikkei reports 02/05/21 Nippon Telegraph - NTTYY
Recommendations	Unibail-Rodamco-Westfield price target lowered to EUR 54 at Deutsche Bank » 14:01 01/22/21 01/22 14:01 01/22/21 14:01 UNBLF Unibail-Rodamco-Westfield $0.00 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research UNBLF Unibail-Rodamco-Westfield $0.00 / + (+0.00%) 01/21/21 Barclays Unibail-Rodamco-Westfield price target lowered to EUR 45 at Barclays 12/10/20 Goldman Sachs Unibail-Rodamco-Westfield upgraded to Buy from Neutral at Goldman Sachs 12/07/20 Deutsche Bank Unibail-Rodamco-Westfield price target lowered to EUR 70 at Deutsche Bank 11/24/20 Goldman Sachs Unibail-Rodamco-Westfield upgraded to Neutral from Sell at Goldman Sachs
On The Fly	Fly Intel: Wall Street's top stories at midday » 13:58 01/22/21 01/22 13:58 01/22/21 13:58 SWIR Sierra Wireless $20.54 / +2.13 (+11.57%) , ALLY Ally Financial $40.62 / +0.7 (+1.75%) , IBM IBM $119.05 / -12.77 (-9.69%) , INTC Intel $57.17 / -5.3 (-8.48%) , STX Seagate $59.29 / -3.71 (-5.89%) , F Ford $11.44 / -0.085 (-0.74%) , WMT Walmart $146.95 / +2.05 (+1.41%) , PASG Passage Bio $19.68 / -3.165 (-13.86%) , PPG PPG $138.71 / -5.225 (-3.63%) Equity futures were… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options SWIR ALLY IBM INTC STX F WMT PASG PPG SWIR Sierra Wireless $20.54 / +2.13 (+11.57%) 01/21/21 Sierra Wireless CEO Thexton to retire 11/18/20 Sierra Wireless completes divestiture of automotive embedded module product line 07/23/20 Sierra Wireless to divest automotive embedded product line for $165M ALLY Ally Financial $40.62 / +0.7 (+1.75%) 07:37 Today Ally Financial reports Q4 net interest margin 2.90%, up 26 bps y/y 01/12/21 Ally Financial announces $1.6B share repurchase plan, declares dividend of 19c 12/08/20 Ally Financial: Core trends 'look really strong' across the bank 12/08/20 Ally Financial sees mid-teens returns over next 1-2 years IBM IBM $119.05 / -12.77 (-9.69%) 09:47 Today IBM falls -8.6% 01/21/21 IBM down 6.5% at $123.24 after Q4 earnings, conference call outlook 01/21/21 IBM sees FY21 'revenue growth based on current spot rates' 01/21/21 IBM NewCo CEO Martin Schroeter says company has 'tremendous potential' INTC Intel $57.17 / -5.3 (-8.48%) 01/21/21 Intel announces 5% increase to quarterly cash dividend 01/21/21 Intel up 7% after early release of Q4 results 01/17/21 Fly Intel: Top five weekend stock stories 01/13/21 Dan Loeb says Intel CEO Bob Swan did 'right thing' to step aside STX Seagate $59.29 / -3.71 (-5.89%) 01/21/21 Seagate says 2020 'a very challenging year' 01/19/21 Nidec files patent infringement suit against Seagate 12/28/20 Seagate appoints Prat Bhatt to Board of Directors 12/16/20 Intel announces next generation of memory and storage products F Ford $11.44 / -0.085 (-0.74%) 01/21/21 Ford sees 2020 underfunded status for pension of about $6.7B 01/21/21 Ford to replace Takata airbag inflators in certain models at cost of $610M 01/19/21 EU passenger car registrations down 3.3% in December 01/11/21 Ford to stop manufacturing in Brazil, sees pre-tax special item charges of $4.1B WMT Walmart $146.95 / +2.05 (+1.41%) 10:57 Today Walmart sees ability to deliver 10M-13M vaccine doses/month when supply allows 01/19/21 MoneyGram slides after Western Union announces pact with Walmart 01/19/21 Western Union jumps 7% to $23.45 after money transfer pact with Walmart 01/19/21 Walmart, Western Union partner to offer Western Union money transfers at Walmart PASG Passage Bio $19.68 / -3.165 (-13.86%) 01/11/21 Passage Bio says PBGM01 entering clinic to study safety, efficacy 01/11/21 Passage Bio announces corporate outlook 01/07/21 Passage Bio gets FDA orphan drug designation in frontotemporal dementia 01/04/21 Passage Bio receives FDA clearance of IND for PBGM01 PPG PPG $138.71 / -5.225 (-3.63%) 01/21/21 PPG says demand continues to improve in many of its end-use markets 01/11/21 PPG appoints Bhaskar Ramachandran as CIO 01/11/21 PPG reaches definitive agreement to acquire Worwag 01/08/21 PPG to acquire VersaFlex Family of Companies SWIR ALLY IBM INTC STX F WMT PASG PPG SWIR Sierra Wireless $20.54 / +2.13 (+11.57%) 07:15 Today Canaccord Sierra Wireless price target raised to $24 from $14 at Canaccord 01/14/21 Fly Intel: Top five analyst initiations 01/14/21 B. Riley Securities Sierra Wireless initiated with a Buy at B. Riley Securities 11/25/20 Colliers Sierra Wireless initiated with a Buy at Colliers ALLY Ally Financial $40.62 / +0.7 (+1.75%) 01/19/21 JPMorgan Ally Financial price target raised to $47 from $32 at JPMorgan 01/13/21 Janney Montgomery Scott Ally Financial price target raised to $45 from $40 at Janney Montgomery Scott 01/13/21 Credit Suisse Ally Financial price target raised to $42 from $34 at Credit Suisse 01/13/21 Citi Ally Financial price target raised to $45 from $33 at Citi IBM IBM $119.05 / -12.77 (-9.69%) 07:01 Today Morgan Stanley IBM miss in software elevates concerns, says Morgan Stanley 10/20/20 Morgan Stanley Morgan Stanley continues to view IBM as 'a 2022 stock' 10/20/20 Citi IBM is 'getting even more complex,' says Citi 10/20/20 BMO Capital IBM price target lowered to $138 from $140 at BMO Capital INTC Intel $57.17 / -5.3 (-8.48%) 09:06 Today Jefferies Intel has 'no easy or quick fix,' says Jefferies 08:59 Today Truist Intel price target raised to $64 from $60 at Truist 08:43 Today Morgan Stanley Intel price target raised to $72 after 'very strong quarter' at Morgan Stanley 07:55 Today Roth Capital Intel price target raised to $60 from $50 at Roth Capital STX Seagate $59.29 / -3.71 (-5.89%) 09:08 Today RBC Capital Seagate price target raised to $61 from $52 at RBC Capital 08:28 Today Craig-Hallum Seagate price target raised to $78 from $65 at Craig-Hallum 07:52 Today Northland Seagate price target raised to $75 from $72 at Northland 07:04 Today Wells Fargo Seagate price target raised to $65 from $50 at Wells Fargo F Ford $11.44 / -0.085 (-0.74%) 09:18 Today JPMorgan JPMorgan upgrades Ford to Overweight ahead of 'hot new products' 05:31 Today JPMorgan Ford upgraded to Overweight from Neutral at JPMorgan 01/20/21 Deutsche Bank Ford price target raised to $11 from $9 at Deutsche Bank 01/20/21 Deutsche Bank Ford named 'Catalyst Call: Buy Idea' at Deutsche Bank WMT Walmart $146.95 / +2.05 (+1.41%) 07:47 Today Jefferies Walmart has upside potential to $200 per share, says Jefferies 01/20/21 Cleveland Research Walmart U.S. sales, share appear to be improving, says Cleveland Research 01/19/21 DA Davidson DA Davidson doesn't see Walmart adding Western Union to hurt Euronet materially 12/21/20 Fly Intel: Top five analyst upgrades PASG Passage Bio $19.68 / -3.165 (-13.86%) 01/04/21 Chardan Lifting hold on PGBM01 a 'broad positive' for Passage Bio pipeline, says Chardan 01/04/21 JPMorgan Passage Bio upgraded to Overweight at JPMorgan after clinical hold lifted 01/04/21 JPMorgan Passage Bio upgraded to Overweight from Neutral at JPMorgan 12/11/20 Citi Passage Bio initiated with a Neutral at Citi PPG PPG $138.71 / -5.225 (-3.63%) 01/20/21 Citi Citi adds PPG to US Focus List, removes FMC 01/14/21 Berenberg PPG upgraded to Buy with $165 price target at Berenberg 01/14/21 Berenberg PPG upgraded to Buy from Hold at Berenberg 12/01/20 Deutsche Bank PPG price target raised to $165 from $155 at Deutsche Bank SWIR ALLY IBM INTC STX F WMT PASG PPG SWIR Sierra Wireless $20.54 / +2.13 (+11.57%) 01/21/21 Sierra Wireless sees Q4 revenue above street consensus of $116.5M 11/12/20 Sierra Wireless cannot estimate COVID-19 impact on Q4 and beyond 11/12/20 Sierra Wireless reports Q3 EPS (19c), consensus (15c) 08/06/20 Sierra Wireless reports Q2 non-GAAP EPS (30c), consensus (35c) ALLY Ally Financial $40.62 / +0.7 (+1.75%) 07:31 Today Ally Financial reports Q4 adjusted EPS $1.60, consensus $1.05 01/21/21 Notable companies reporting before tomorrow's open 01/21/21 Notable companies reporting before tomorrow's open 10/16/20 Ally Financial reports Q3 adjusted EPS $1.25, consensus 68c IBM IBM $119.05 / -12.77 (-9.69%) 01/21/21 IBM reports Q4 Cloud & Cognitive Software revenue $6.8B, down 4.5% 01/21/21 IBM reports Q4 adjusted EPS $2.07, consensus $1.79 01/21/21 Notable companies reporting after market close 10/19/20 IBM reports Q3 Cloud & Cognitive Software revenue $5.6B, up 7% INTC Intel $57.17 / -5.3 (-8.48%) 01/21/21 Intel sees Q1 EPS $1.10, consensus 93c 01/21/21 Intel reports Q4 EPS $1.52, consensus $1.10 01/21/21 Notable companies reporting after market close 01/13/21 Intel sees Q4 revenue and EPS to exceed prior guidance STX Seagate $59.29 / -3.71 (-5.89%) 01/21/21 Seagate sees Q3 adjusted EPS $1.30, plus/minus 15c, consensus $1.26 01/21/21 Seagate reports Q2 adjusted EPS $1.29, consensus $1.13 10/22/20 Seagate sees Q2 adjusted EPS $1.10, plus/minus 15c, consensus $1.08 10/22/20 Seagate reports Q1 adjusted EPS 93c, consensus 88c F Ford $11.44 / -0.085 (-0.74%) 10/28/20 Ford sees temporarily lower F-150 wholesale shipments in Q4 10/28/20 Ford reports Q3 adjusted EBIT $3.6B 10/28/20 Ford reports Q3 adjusted EPS 65c, consensus 16c 10/28/20 Notable companies reporting after market close WMT Walmart $146.95 / +2.05 (+1.41%) 11/17/20 Walmart reports Q3 adjusted EPS $1.34, consensus $1.18 11/16/20 Notable companies reporting before tomorrow's open 11/16/20 Notable companies reporting before tomorrow's open 08/18/20 Walmart reports Q2 adjusted EPS $1.56, consensus $1.25 PASG Passage Bio $19.68 / -3.165 (-13.86%) 11/10/20 Passage Bio reports Q3 EPS (63c), consensus (76c) 08/13/20 Passage Bio reports Q2 EPS (60c), consensus (57c) PPG PPG $138.71 / -5.225 (-3.63%) 07:10 Today PPG sees Q1 adjusted EPS $1.55-$1.61, consensus $1.89 01/21/21 PPG reports Q4 EPS $1.59, consensus $1.58 01/21/21 Notable companies reporting after market close 10/19/20 PPG sees Q4 adjusted EPS $1.50-$1.57, consensus $1.44 22 Jan 28 Feb IBM INTC F WMT IBM IBM $119.05 / -12.77 (-9.69%) 01/14/21 IBM buying cloud computing consultant Taos Mountain, WSJ reports 01/06/21 IBM restructuring sales organization, WSJ reports 11/25/20 IBM to eliminate 10,000 positions in Europe ahead of unit sale, Bloomberg says 10/11/20 IBM split might not mean speedy recovery, WSJ says INTC Intel $57.17 / -5.3 (-8.48%) 01/21/21 Intel says hacker gained access to financially sensitive data, FT reports 01/17/21 Trump admin slams China's Huawei, halting shipments from Intel, Reuters says 01/16/21 Intel rebound will still take time, Barron's says 01/15/21 Intel may fully advance to 10nm in 2021, DigiTimes reports F Ford $11.44 / -0.085 (-0.74%) 01/19/21 Amazon and Ford backed EV Truck-maker Rivian raises another $2.65B, WSJ says 01/08/21 Ford to idle Kentucky plant, blames microchip shortage, Detroit News reports 01/05/21 Rivian close to raising funds at $25B valuation, Bloomberg says 01/05/21 Rivian close to raising funds at $25B valuation, Bloomberg says WMT Walmart $146.95 / +2.05 (+1.41%) 07:57 Today Walmart to expand vaccination program, Reuters reports 01/20/21 Watchdog challenges Walmart's 'Made in USA' claims, NY Post reports 01/12/21 Walmart, Disney halt donations to lawmakers against Biden win, Bloomberg says 01/12/21 Walmart building new health venture, Business Insider reports SWIR ALLY IBM INTC STX F WMT PPG SWIR Sierra Wireless $20.54 / +2.13 (+11.57%) 01/21/21 Fly Intel: After-Hours Movers ALLY Ally Financial $40.62 / +0.7 (+1.75%) 08:55 Today Fly Intel: Pre-market Movers 01/12/21 Fly Intel: After-Hours Movers 10/16/20 Fly Intel: Pre-market Movers IBM IBM $119.05 / -12.77 (-9.69%) 08:55 Today Fly Intel: Pre-market Movers 01/21/21 Fly Intel: After-Hours Movers 01/21/21 Fly Intel: What to watch in IBM's earnings report 01/05/21 Fly Intel: Wall Street's top stories for Tuesday INTC Intel $57.17 / -5.3 (-8.48%) 08:55 Today Fly Intel: Pre-market Movers 01/21/21 Fly Intel: What to watch in Intel's earnings report 01/14/21 Fly Intel: Wall Street's top stories for Thursday 01/14/21 Fly Intel: Wall Street's top stories at midday STX Seagate $59.29 / -3.71 (-5.89%) 01/21/21 Fly Intel: After-Hours Movers 12/28/20 Kinnate initiations, Nikola target change among today's top calls on Wall Street 10/23/20 Fly Intel: Wall Street's top stories for Friday 10/23/20 Fly Intel: Wall Street's top stories at midday F Ford $11.44 / -0.085 (-0.74%) 09:34 Today Disney, Ford upgrades among today's top calls on Wall Street 01/21/21 Fly Intel: After-Hours Movers 01/11/21 Fly Intel: Wall Street's top stories for Monday 12/26/20 Charged: Apple's potential EV entry seen as 'Tesla bear case' WMT Walmart $146.95 / +2.05 (+1.41%) 01/12/21 Fly Intel: Wall Street's top stories for Tuesday 01/12/21 Fly Intel: Wall Street's top stories at midday 01/11/21 Fly Intel: After-Hours Movers 12/22/20 Fly Intel: Wall Street's top stories for Tuesday PPG PPG $138.71 / -5.225 (-3.63%) 08:55 Today Fly Intel: Pre-market Movers 01/21/21 Fly Intel: After-Hours Movers 10/19/20 Fly Intel: After-Hours Movers 10/09/20 GE reinstatement at Goldman among today's top calls on Wall Street 02/08/21 17th Annual Virtual WORLDSymposium 2021 03/01/21 41st Annual Healthcare Virtual Conference 08:00 Today PPG - PPG 09:00 Today Ally Financial - ALLY 02/04/21 Ford - F 02/18/21 Walmart - WMT 04/22/21 Intel - INTC ALLY IBM INTC STX F WMT PASG PPG ALLY Ally Financial $40.62 / +0.7 (+1.75%) 09:40 Today Unusually active option classes on open January 22nd 01/21/21 Unusually active option classes on open January 21st 10/30/20 Ally Financial put volume heavy and directionally bearish 10/20/20 Ally Financial call volume above normal and directionally bullish IBM IBM $119.05 / -12.77 (-9.69%) 01/21/21 IBM options imply 6.3% move in share price post-earnings 01/05/21 Unusually active option classes on open January 5th 10/30/20 IBM call volume above normal and directionally bullish 10/19/20 IBM options imply 6.1% move in share price post-earnings INTC Intel $57.17 / -5.3 (-8.48%) 08:55 Today Notable open interest changes for January 22nd 01/21/21 Intel options imply 9.0% move in share price post-earnings 01/13/21 Early notable gainers among liquid option names on January 13th 01/13/21 Intel call volume above normal and directionally bullish STX Seagate $59.29 / -3.71 (-5.89%) 01/21/21 Seagate options imply 7.9% move in share price post-earnings 12/28/20 Largest borrow rate increases among liquid names 12/21/20 Seagate call volume above normal and directionally bullish 12/01/20 Seagate call volume above normal and directionally bullish F Ford $11.44 / -0.085 (-0.74%) 11:00 Today September risk reversal in Ford suggests bullish medium-term view 08:55 Today Notable open interest changes for January 22nd 07:35 Today Unusual call flow in option market yesterday 01/21/21 Ford call volume off to the races as shares and implied volatility surge WMT Walmart $146.95 / +2.05 (+1.41%) 11/17/20 Unusually active option classes on open November 17th 09/02/20 Notable open interest changes for September 2nd 09/02/20 Wal-Mart call buyer realizes 124% same-day gains 09/01/20 Early notable gainers among liquid option names on September 1st PASG Passage Bio $19.68 / -3.165 (-13.86%) 12/09/20 Nine new option listings on December 9th PPG PPG $138.71 / -5.225 (-3.63%) 10/19/20 PPG Industries options imply 4.4% move in share price post-earnings
Hot Stocks	Penn National CEO expects to be live in 10 states by year-end » 13:54 01/22/21 01/22 13:54 01/22/21 13:54 PENN Penn National $107.78 / +0.45 (+0.42%) Jay Snowden is speaking… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options PENN Penn National $107.78 / +0.45 (+0.42%) 13:54 Today Penn National CEO says 'working hard' at finding way into New York gambling 01/20/21 Barstool's Portnoy says 'pray for everybody else' if profitability matters 01/19/21 Penn National announces online sports wagering approval in Michigan 01/13/21 New Jersey reports December gaming revenue up 8.9% to $312.9M PENN Penn National $107.78 / +0.45 (+0.42%) 01/21/21 Fly Intel: Top five analyst initiations 01/20/21 Fly Intel: Top five analyst initiations 01/20/21 Credit Suisse Penn National initiated with an Outperform at Credit Suisse 01/14/21 Fly Intel: Top five analyst downgrades PENN Penn National $107.78 / +0.45 (+0.42%) 10/29/20 Penn National reports Q3 EPS 93c, consensus 53c 10/28/20 Notable companies reporting before tomorrow's open 10/28/20 Notable companies reporting before tomorrow's open 08/06/20 Penn National reports Q2 EPS ($1.69), consensus ($2.11) 25 Sep 12 May PENN Penn National $107.78 / +0.45 (+0.42%) 01/21/21 Japan expects Tokyo Olympics will have to be cancelled, The Times says 01/11/21 NBA postones Pelicans-Mavs, Celtics-Bulls games 01/08/21 Las Vegas Sands could shift strategy towards sports betting, Bloomberg says 01/08/21 Las Vegas Sands in talks for online sports betting, Bloomberg reports PENN Penn National $107.78 / +0.45 (+0.42%) 01/15/21 Bet On It: New Jersey handle ranks highest in 2020 01/08/21 Bet On It: New York warming up to online sports betting 01/06/21 DraftKings rises on Gov. Cuomo's endorsement of mobile betting in NY 12/31/20 Bet On It: Rush Street Interactive completes SPAC merger, exceeds expectations 02/04/21 Penn National - PENN PENN Penn National $107.78 / +0.45 (+0.42%) 01/12/21 Penn National call volume above normal and directionally bullish 12/16/20 Penn National call volume above normal and directionally bullish 12/14/20 Penn National call volume above normal and directionally bullish 12/08/20 Penn National call volume above normal and directionally bullish
Hot Stocks	Penn National CEO says 'working hard' at finding way into New York gambling » 13:54 01/22/21 01/22 13:54 01/22/21 13:54 PENN Penn National $107.75 / +0.42 (+0.39%) Jay Snowden is speaking… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options PENN Penn National $107.75 / +0.42 (+0.39%) 01/20/21 Barstool's Portnoy says 'pray for everybody else' if profitability matters 01/19/21 Penn National announces online sports wagering approval in Michigan 01/13/21 New Jersey reports December gaming revenue up 8.9% to $312.9M 01/13/21 Choice Hotels announces loyalty program agreement with Penn National Gaming PENN Penn National $107.75 / +0.42 (+0.39%) 01/21/21 Fly Intel: Top five analyst initiations 01/20/21 Fly Intel: Top five analyst initiations 01/20/21 Credit Suisse Penn National initiated with an Outperform at Credit Suisse 01/14/21 Fly Intel: Top five analyst downgrades PENN Penn National $107.75 / +0.42 (+0.39%) 10/29/20 Penn National reports Q3 EPS 93c, consensus 53c 10/28/20 Notable companies reporting before tomorrow's open 10/28/20 Notable companies reporting before tomorrow's open 08/06/20 Penn National reports Q2 EPS ($1.69), consensus ($2.11) 25 Sep 12 May PENN Penn National $107.75 / +0.42 (+0.39%) 01/21/21 Japan expects Tokyo Olympics will have to be cancelled, The Times says 01/11/21 NBA postones Pelicans-Mavs, Celtics-Bulls games 01/08/21 Las Vegas Sands could shift strategy towards sports betting, Bloomberg says 01/08/21 Las Vegas Sands in talks for online sports betting, Bloomberg reports PENN Penn National $107.75 / +0.42 (+0.39%) 01/15/21 Bet On It: New Jersey handle ranks highest in 2020 01/08/21 Bet On It: New York warming up to online sports betting 01/06/21 DraftKings rises on Gov. Cuomo's endorsement of mobile betting in NY 12/31/20 Bet On It: Rush Street Interactive completes SPAC merger, exceeds expectations 02/04/21 Penn National - PENN PENN Penn National $107.75 / +0.42 (+0.39%) 01/12/21 Penn National call volume above normal and directionally bullish 12/16/20 Penn National call volume above normal and directionally bullish 12/14/20 Penn National call volume above normal and directionally bullish 12/08/20 Penn National call volume above normal and directionally bullish

Recommendations	Klepierre price target lowered to EUR 21.50 from EUR 23 at Deutsche Bank » 13:53 01/22/21 01/22 13:53 01/22/21 13:53 KLPEF Klepierre $0.00 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research KLPEF Klepierre $0.00 / + (+0.00%) 01/18/21 BofA Klepierre downgraded to Underperform from Neutral at BofA 01/15/21 JPMorgan Klepierre price target lowered to EUR 20 from EUR 22 at JPMorgan 12/10/20 Goldman Sachs Klepierre upgraded to Neutral from Sell at Goldman Sachs 11/20/20 RBC Capital Klepierre price target raised to EUR 25 from EUR 23 at RBC Capital
Recommendations	Lundin Mining price target raised to SEK 92.50 from SEK 91 at Deutsche Bank » 13:52 01/22/21 01/22 13:52 01/22/21 13:52 LUNMF Lundin Mining $0.00 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research LUNMF Lundin Mining $0.00 / + (+0.00%) 01/21/21 BMO Capital Lundin Mining price target raised to C$13.50 from C$13 at BMO Capital 01/15/21 Raymond James Lundin Mining price target raised to C$12 from C$8.50 at Raymond James 01/14/21 JPMorgan Lundin Mining price target raised to SEK 82 from SEK 61 at JPMorgan 01/13/21 Deutsche Bank Lundin Mining initiated with a Buy at Deutsche Bank
Options	SunPower call volume above normal and directionally bullish » 13:45 01/22/21 01/22 13:45 01/22/21 13:45 SPWR SunPower $45.51 / +1.76 (+4.02%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SPWR SunPower $45.51 / +1.76 (+4.02%) 01/07/21 SunPower closing manufacturing facility in Hillsboro, Oregon 01/07/21 Hannon Armstrong announces leadership moves, promotes Jeffrey Lipson to COO 08/27/20 Total 'fully supports' SunPower spin-off of Maxeon Solar 08/27/20 SunPower, Maxeon Solar complete spin-off transaction SPWR SunPower $45.51 / +1.76 (+4.02%) 01/20/21 JPMorgan SunPower price target raised to $25 from $21 at JPMorgan 01/20/21 Credit Suisse SunPower price target raised to $23 from $16 at Credit Suisse 01/19/21 Piper Sandler SunPower price target raised to $35 from $22 at Piper Sandler 01/12/21 Fly Intel: Top five analyst initiations SPWR SunPower $45.51 / +1.76 (+4.02%) 10/28/20 SunPower raises 2020 non-GAAP revenue view to $1.12-$1.16B from $1.06B-$1.10B 10/28/20 SunPower still sees Q4 revenue $330M-$370M, consensus $350.28M 10/28/20 SunPower reports Q3 non-GAAP EPS (4c), consensus (5c) 10/28/20 Notable companies reporting after market close SPWR SunPower $45.51 / +1.76 (+4.02%) 11/11/20 Former Google exec seen as 'top' Biden energy pick, Bloomberg reports SPWR SunPower $45.51 / +1.76 (+4.02%) 01/16/21 Charged: NIO unveils new sedan, Plug partners with Renault 12/26/20 Charged: Apple's potential EV entry seen as 'Tesla bear case' 12/26/20 Week in review: How Trump's policies moved stocks 12/19/20 Charged: Deutsche sees multiple EV winners, says buy Xpev 03/15/21 33rd Annual Roth Virtual Conference SPWR SunPower $45.51 / +1.76 (+4.02%) 01/14/21 SunPower call volume above normal and directionally bullish 11/04/20 Unusually active option classes on open November 4th 11/03/20 SunPower put volume heavy and directionally bearish 10/20/20 SunPower call volume above normal and directionally bullish
Initiation	CyberAgent initiated with a Neutral at Goldman Sachs » 13:43 01/22/21 01/22 13:43 01/22/21 13:43 CYAGF CyberAgent $0.00 / + (+0.00%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research CYAGF CyberAgent $0.00 / + (+0.00%) 04/07/20 Jefferies CyberAgent downgraded to Hold from Buy at Jefferies
General news	Oil Action: The weekly Baker Hughes oil rig count » 13:35 01/22/21 01/22 13:35 01/22/21 13:35 Oil Action: The weekly… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial

Hot Stocks	AIkido Pharma regains compliance with Nasdaq listing requirements » 13:32 01/22/21 01/22 13:32 01/22/21 13:32 AIKI AIkido Pharma $1.18 / -0.035 (-2.88%) AIkido Pharma announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News AIKI AIkido Pharma $1.18 / -0.035 (-2.88%) 01/06/21 AIkido Pharma executes licensing agreement for psilocybin in cancer applications 12/09/20 AIkido Pharma announces AI/ML publication in field of pancreatic cancer 11/13/20 AIkido Pharma reports positive results of licensed antiviral platform 10/28/20 AIkido Pharma issues update on preclinical work on DHA-dFdC
Initiation	Z Holdings initiated with a Buy at Goldman Sachs » 13:29 01/22/21 01/22 13:29 01/22/21 13:29 YAHOY Z Holdings $0.00 / + (+0.00%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Recommendations	Bankinter price target raised to EUR 5.35 from EUR 5.25 at Deutsche Bank » 13:26 01/22/21 01/22 13:26 01/22/21 13:26 BKIMF Bankinter $0.00 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research BKIMF Bankinter $0.00 / + (+0.00%) 01/20/21 UBS Bankinter price target raised to EUR 4.60 from EUR 3.45 at UBS 12/14/20 JPMorgan Bankinter price target raised to EUR 3.60 from EUR 3.30 at JPMorgan 11/24/20 Morgan Stanley Bankinter price target raised to EUR 4.15 from EUR 3.90 at Morgan Stanley 10/23/20 Barclays Bankinter price target lowered to EUR 3.60 from EUR 3.80 at Barclays
Recommendations	Hargreaves Lansdown price target raised to 1,700 GBp at Deutsche Bank » 13:25 01/22/21 01/22 13:25 01/22/21 13:25 HRGLY Hargreaves Lansdown $0.00 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research HRGLY Hargreaves Lansdown $0.00 / + (+0.00%) 11:53 Today Canaccord Hargreaves Lansdown price target raised to 1,695 GBp at Canaccord 01/12/21 Morgan Stanley Hargreaves Lansdown price target raised to 1,427 GBp at Morgan Stanley 01/12/21 JPMorgan Hargreaves Lansdown price target raised to 1,450 GBp from 1,390 GBp at JPMorgan 01/08/21 Barclays Hargreaves Lansdown price target lowered to 1,925 GBp at Barclays
Options	Camping World call volume above normal and directionally bullish » 13:25 01/22/21 01/22 13:25 01/22/21 13:25 CWH Camping World $35.85 / +0.91 (+2.60%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options CWH Camping World $35.85 / +0.91 (+2.60%) 12/16/20 Camping World, Lordstown Motors partner on EV service network 11/24/20 Camping World acquires Paul Sherry RV in Piqua Ohio 11/19/20 Camping World to acquire All RV Needs in Oregon 11/18/20 Camping World declares quarterly and special dividend totaling $1.00 per share CWH Camping World $35.85 / +0.91 (+2.60%) 01/20/21 Monness Crespi Peer's results show positive read-through for Camping World, says Monness Crespi 12/16/20 JPMorgan JPMorgan reiterates $45 target on Camping World after Lordstown pact 11/04/20 BMO Capital Camping World price target lowered to $30 from $36 at BMO Capital 09/28/20 JPMorgan RV shipments rose for third straight month in August, says JPMorgan CWH Camping World $35.85 / +0.91 (+2.60%) 11/02/20 Camping World CEO confirms previously issued FY21 adjusted EBITDA target 11/02/20 Camping World raises FY20 adjusted EBITDA view to $495M-$515M from $460M-$490M 11/02/20 Camping World reports Q3 EPS $1.44, consensus 96c 08/05/20 Camping World sees 2020 as company's 'most profitable' year ever 20 Aug CWH Camping World $35.85 / +0.91 (+2.60%) 12/15/20 Lordstown, Camping World to make 'special announcement,' WKBN says CWH Camping World $35.85 / +0.91 (+2.60%) 12/19/20 Charged: Deutsche sees multiple EV winners, says buy Xpev 11/16/20 Fly Insider: Cerevel Therapeutics, Paylocity among weeks notable insider trades 11/02/20 Fly Intel: Wall Street's top stories for Monday 11/02/20 Fly Intel: Wall Street's top stories at midday 02/25/21 Camping World - CWH CWH Camping World $35.85 / +0.91 (+2.60%) 01/21/21 Camping World call volume above normal and directionally bullish 12/16/20 Call trader flips Camping World calls for 1day loss 12/16/20 Unusually active option classes on open December 16th 12/15/20 Camping World call volume above normal and directionally bullish

Recommendations	PSP Swiss Property price target raised to CHF 120 from CHF 103 at Deutsche Bank » 13:24 01/22/21 01/22 13:24 01/22/21 13:24 PSPSF PSP Swiss Property $0.00 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research PSPSF PSP Swiss Property $0.00 / + (+0.00%) 08/21/20 JPMorgan PSP Swiss Property upgraded to Neutral from Underweight at JPMorgan 08/19/20 Deutsche Bank PSP Swiss Property price target raised to CHF 103 from CHF 102 at Deutsche Bank 06/09/20 Berenberg PSP Swiss Property price target lowered to CHF 130 from CHF 132 at Berenberg 05/11/20 Morgan Stanley PSP Swiss Property price target lowered to CHF 90 at Morgan Stanley
Recommendations	Entain price target raised to 1,601 GBp from 1,351 GBp at Deutsche Bank » 13:22 01/22/21 01/22 13:22 01/22/21 13:22 GMVHF Entain $0.00 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly GMVHF Entain $0.00 / + (+0.00%) 01/19/21 Entain responds to MGM announcement, looks forward to continuing JV success 01/19/21 MGM Resorts jumps 6% to $31.50 after announcing it won't bid for Entain 01/19/21 MGM Resorts says will not make a firm offer for Entain 01/11/21 Washington Nationals, BetMGM announce multi-year partnership GMVHF Entain $0.00 / + (+0.00%) 01/19/21 Berenberg Entain price target raised to 1,730 GBp from 1,175 GBp at Berenberg 01/19/21 Macquarie MGM walking away from Entain shows discipline, says Macquarie 01/19/21 Jefferies Entain remains 'highly attractive' after MGM doesn't bid, says Jefferies 01/19/21 Berenberg Entain price target raised to 1,730 GBp from 1,175 GBp at Berenberg GMVHF Entain $0.00 / + (+0.00%) 01/03/21 MGM makes new offer to acquire gaming company Entain, WSJ reports GMVHF Entain $0.00 / + (+0.00%) 01/19/21 DraftKings slips as analyst says sell on 'overoptimistic' share estimates 01/08/21 Bet On It: New York warming up to online sports betting 12/04/20 Bet On It: Michigan clears path for online gambling 10/16/20 Friday Parlay: NJ results seen as push on prospective states toward legalization
Recommendations	Commerzbank price target raised to EUR 6 from EUR 4 at Deutsche Bank » 13:22 01/22/21 01/22 13:22 01/22/21 13:22 CRZBY Commerzbank $0.00 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals CRZBY Commerzbank $0.00 / + (+0.00%) 09/28/20 Deutsche Bank's Manfred Knof named as new Commerzbank CEO 08/03/20 Commerzbank names Hans-Joerg Vetter chairman of the board CRZBY Commerzbank $0.00 / + (+0.00%) 01/20/21 RBC Capital Commerzbank price target raised to EUR 6.50 from EUR 5.50 at RBC Capital 11/06/20 Credit Suisse Commerzbank price target lowered to EUR 5 from EUR 5.10 at Credit Suisse 10/16/20 Credit Suisse Commerzbank initiated with a Neutral at Credit Suisse 09/14/20 UBS Commerzbank downgraded to Sell from Neutral at UBS CRZBY Commerzbank $0.00 / + (+0.00%) 01/13/21 UniCredit considers Orcel, Thiam for CEO role, FT reports
Hot Stocks	Bristol-Myers announces approval of Opdivo plus Cabometyx for carcinoma » 13:21 01/22/21 01/22 13:21 01/22/21 13:21 BMY Bristol-Myers $64.78 / +0.59 (+0.92%) Bristol Myers Squibb… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BMY Bristol-Myers $64.78 / +0.59 (+0.92%) 01/20/21 Bristol-Myers: FDA accepts for Priority Review sBLA for Opdivo combination 01/11/21 Bristol-Myers CEO: Our strategy for growth is based on innovation 01/11/21 Illumina announces new and expanded oncology partnerships 01/11/21 Bristol-Myers announces $2B incremental share repurchase plan BMY Bristol-Myers $64.78 / +0.59 (+0.92%) 01/20/21 William Blair Exelixis selloff on competitive concerns an 'overreaction,' says William Blair 01/20/21 Citi Citi opens 'negative Catalyst Watch' on Bristol-Myers 12/15/20 Goldman Sachs Bristol-Myers upgraded to Conviction Buy from Buy at Goldman Sachs 12/09/20 Mizuho Pentwater seeks to replace Bristol-Myers Squibb CVR trustee, says Mizuho BMY Bristol-Myers $64.78 / +0.59 (+0.92%) 11/05/20 Bristol-Myers backs FY21 EPS view $7.15-$7.45, consensus $7.39 11/05/20 Bristol-Myers raises FY20 EPS view to $6.25-$6.35 from $6.10-$6.25 11/05/20 Bristol-Myers reports Q3 EPS $1.63, consensus $1.49 11/04/20 Notable companies reporting before tomorrow's open BMY Bristol-Myers $64.78 / +0.59 (+0.92%) 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says 11/20/20 Trump to release new rules aimed at lowering drug prices, WSJ reports 10/05/20 Bristol-Myers to buy MyoKardia for $13.1B, or $225/share in cash, WSJ reports BMY Bristol-Myers $64.78 / +0.59 (+0.92%) 12/26/20 Week in review: How Trump's policies moved stocks 11/21/20 Week in review: How Trump's policies moved stocks 11/05/20 Fly Intel: Pre-market Movers 10/08/20 Cytokinetics plunges following mixed results from heart drug trial 01/26/21 Pharmacovigilance & Risk Management Strategies Virtual Conference 03/01/21 41st Annual Healthcare Virtual Conference 02/04/21 Bristol-Myers - BMY 02/20/21 PDUFA Date for OPDIVO / CABOMETYX bmy 03/27/21 PDUFA Date for Ide-Cel BMY Bristol-Myers $64.78 / +0.59 (+0.92%) 01/20/21 Unusually active option classes on open January 20th 01/11/21 Unusually active option classes on open January 11th 01/05/21 Bristol Myers Squibb call volume above normal and directionally bullish 01/04/21 Bristol Myers Squibb call buyer realizes 25% same-day gains
Technical Analysis	NASDAQ market internals summary » 13:17 01/22/21 01/22 13:17 01/22/21 13:17 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 12:17 Today NASDAQ market internals summary 11:17 Today NASDAQ market internals summary 10:17 Today NASDAQ market internals summary 01/21/21 NASDAQ market internals summary

Technical Analysis	NYSE market internals summary » 13:16 01/22/21 01/22 13:16 01/22/21 13:16 $NYE NYSE Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals $0.00 / + (+0.00%) 12:16 Today NYSE market internals summary 11:16 Today NYSE market internals summary 10:16 Today NYSE market internals summary 01/21/21 NYSE market internals summary
Hot Stocks	Exelixis announces FDA approval of CABOMETYX in combination with OPDIVO » 13:12 01/22/21 01/22 13:12 01/22/21 13:12 EXEL Exelixis $21.63 / +0.3 (+1.41%) Exelixis announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events EXEL Exelixis $21.63 / +0.3 (+1.41%) 12/21/20 Exelixis announces cabozantinib trial meets co-primary endpoint 12/07/20 Exelixis in-licenses Aurigene's novel CDK7 inhibitor, files IND 12/07/20 Exelixis in-licenses Aurigene's novel CDK7 inhibitor, files IND 12/02/20 Exelixis exercises option for Iconic's ADC, to develop under May 2019 pact EXEL Exelixis $21.63 / +0.3 (+1.41%) 01/20/21 William Blair Exelixis selloff on competitive concerns an 'overreaction,' says William Blair 12/14/20 William Blair Calithera risk/reward attractive into CANTATA readout, says William Blair 10/26/20 Piper Sandler Exelixis could have successor to Cabometyx with XL092, says Piper Sandler 09/22/20 Morgan Stanley Exelixis price target raised to $29 from $23 at Morgan Stanley EXEL Exelixis $21.63 / +0.3 (+1.41%) 01/10/21 Exelixis sees FY21 revenue $1.15B-$1.25B, consensus $1.16B 01/10/21 Exelixis reports preliminary Q4 revenue $270M, consensus $213.78M 11/05/20 Exelixis sees FY20 revenue $900M-$950M, consensus $922M 11/05/20 Exelixis reports Q3 adjusted EPS 4c, consensus 1c 03/01/21 41st Annual Healthcare Virtual Conference 02/20/21 PDUFA Date for OPDIVO / CABOMETYX bmy
Hot Stocks	Baker Hughes reports U.S. rig count up 5 to 378 rigs » 13:11 01/22/21 01/22 13:11 01/22/21 13:11 BKR Baker Hughes $22.15 / -0.41 (-1.82%) Baker Hughes reports that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events BKR Baker Hughes $22.15 / -0.41 (-1.82%) 13:01 Today Baker Hughes reports U.S. rig count up 5 to 378 rigs 01/15/21 Baker Hughes reports U.S. rig count up 13 to 373 rigs 01/15/21 Baker Hughes reports U.S. rig count up 13 to 373 rigs 01/08/21 Baker Hughes reports U.S. rig count up 9 to 360 rigs BKR Baker Hughes $22.15 / -0.41 (-1.82%) 09:18 Today Morgan Stanley Baker Hughes price target raised to $26 after earnings at Morgan Stanley 01/13/21 JPMorgan JPMorgan announces top 10 energy picks for 2021 01/08/21 Barclays Baker Hughes downgraded to Equal Weight from Overweight at Barclays 12/18/20 JPMorgan Baker Hughes price target raised to $23 from $20 at JPMorgan BKR Baker Hughes $22.15 / -0.41 (-1.82%) 01/21/21 Baker Hughes reports Q4 adjusted EPS (7c), consensus 17c 10/21/20 Baker Hughes reports Q3 EPS 4c, consensus 4c 10/20/20 Notable companies reporting before tomorrow's open 10/20/20 Notable companies reporting before tomorrow's open BKR Baker Hughes $22.15 / -0.41 (-1.82%) 11/11/20 OPEC+ discussing possible 3-to-6 month delay of production hikes, Bloomberg says BKR Baker Hughes $22.15 / -0.41 (-1.82%) 10/21/20 Fly Intel: Pre-market Movers 03/01/21 26th Annual Energy Virtual Summit
Hot Stocks	Baker Hughes reports U.S. rig count up 5 to 378 rigs 13:01 01/22/21 01/22 13:01 01/22/21 13:01 BKR Baker Hughes $21.97 / -0.59 (-2.62%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events BKR Baker Hughes $21.97 / -0.59 (-2.62%) 01/15/21 Baker Hughes reports U.S. rig count up 13 to 373 rigs 01/15/21 Baker Hughes reports U.S. rig count up 13 to 373 rigs 01/08/21 Baker Hughes reports U.S. rig count up 9 to 360 rigs 01/08/21 Baker Hughes reports U.S. rig count up 9 to 360 rigs BKR Baker Hughes $21.97 / -0.59 (-2.62%) 09:18 Today Morgan Stanley Baker Hughes price target raised to $26 after earnings at Morgan Stanley 01/13/21 JPMorgan JPMorgan announces top 10 energy picks for 2021 01/08/21 Barclays Baker Hughes downgraded to Equal Weight from Overweight at Barclays 12/18/20 JPMorgan Baker Hughes price target raised to $23 from $20 at JPMorgan BKR Baker Hughes $21.97 / -0.59 (-2.62%) 01/21/21 Baker Hughes reports Q4 adjusted EPS (7c), consensus 17c 10/21/20 Baker Hughes reports Q3 EPS 4c, consensus 4c 10/20/20 Notable companies reporting before tomorrow's open 10/20/20 Notable companies reporting before tomorrow's open BKR Baker Hughes $21.97 / -0.59 (-2.62%) 11/11/20 OPEC+ discussing possible 3-to-6 month delay of production hikes, Bloomberg says BKR Baker Hughes $21.97 / -0.59 (-2.62%) 10/21/20 Fly Intel: Pre-market Movers 03/01/21 26th Annual Energy Virtual Summit
Upgrade	Icade upgraded to Buy from Hold at Deutsche Bank » 12:57 01/22/21 01/22 12:57 01/22/21 12:57 CDMGF Icade $0.00 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research CDMGF Icade $0.00 / + (+0.00%) 01/19/21 Barclays Icade price target lowered to EUR 67 from EUR 68 at Barclays 11/09/20 Goldman Sachs Icade upgraded to Neutral from Sell at Goldman Sachs 10/23/20 Deutsche Bank Icade price target lowered to EUR 74 from EUR 99 at Deutsche Bank 10/20/20 BofA Icade upgraded to Buy from Neutral at BofA

Events

Earnings calls, analyst events, roadshows and more

Tomorrow at 00:00

2021 VESS Annual Winter Meeting Conferences

Virtual Meeting
PFE
2021-01-24 at 00:00

PDUFA Date for Xalkori (Crizotinib) - January 2021 Government Event
2021-01-24 at 00:00

2021 VESS Annual Winter Meeting Conferences

Virtual Meeting
2021-01-25 at 00:00

Annual Virtual Washington DC Energy & Power Policy Field Trip Conferences

Virtual Field Trip
NBAC
2021-01-25 at 00:00

Newborn Acquisition Corp. Firm Sponsored Meetings

Virtual Meeting
USB
2021-01-25 at 00:00

U.S. Bancorp Firm Sponsored Meetings

Virtual Meeting
SEEL
2021-01-25 at 00:00

Seelos Therapeutics Firm Sponsored Meetings

Virtual Meeting
FDX
2021-01-25 at 00:00

FedEx Firm Sponsored Meetings

Virtual Meeting
NAVB
2021-01-25 at 00:00

Navidea Firm Sponsored Meetings

Virtual Meeting
2021-01-25 at 00:00

Healthcare Industry Meetings

Virtual Meeting

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	BDGE X BDGE Bridge Bancorp Block Trade Managers: Morgan Stanley Priced at: $25.50 700K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital Priced at: $30.50 4.59M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright Priced at: $17.50 5.484M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald Priced at: $1.90 14.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BLRX X BLRX BioLineRx Spot Secondary Managers: H.C. Wainwright Priced at: $2.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNGO X BNGO Bionano Genomics Spot Secondary Managers: Oppenheimer, BTIG, Ladenburg, Maxim Priced at: $6.00 33.333M Shares DSS X DSS Document Security Spot Secondary Managers: Aegis Priced at: $3.60 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: SVB Leerink, Piper Sandler & Credit Suisse Priced at: $11.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAC X LAC Lithium Americas Spot Secondary Managers: Canaccord, Deutsche Bank, Evercore ISI, Stifel Priced at: $22.00 15.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PERI X PERI Perion Network Spot Secondary Managers: Oppenheimer, Stifel, Roth Capital, LAKE Priced at: $11.50 4.99M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYRS X SYRS Syros Pharmaceuticals Spot Secondary Managers: Cowen & Piper Sandler Priced at: $14.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush Priced at: $13.00 9.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen Priced at: $26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities Priced at: $22.50 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDNA X CDNA CareDx Secondary Managers: Goldman Sachs & Jefferies, Raymond James, BTIG, Craig-Hallum, H.C. Wainwright Priced at: $91.00 1.923M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading Priced at: $8.50 11.765M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTMX X CTMX CytomX Therapeutics Secondary Managers: JPMorgan, Cowen & Piper Sandler Priced at: $7.00 14.286M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel Priced at: $28.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse Priced at: $66.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink Priced at: $24.75 4.85M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Spot Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS Priced at: $66.00 3.788M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INO X INO Inovio Spot Secondary Managers: BofA, Jefferies & Cantor Fitzgerald, Oppenheimer Priced at: $8.50 2.655M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ONCS X ONCS OncoSec Spot Secondary Managers: BTIG Priced at: $5.45 7.71M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.30 7.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	VRAY X VRAY ViewRay Block Trade Managers: Morgan Stanley Priced at: $4.75 11.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP Priced at: $17.00 30.099M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance Priced at: $12.00 116.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AZEK X AZEK Azek Secondary Managers: Barclays, BofA, Goldman Sachs & Jefferies Priced at: $40.00 20M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CRSR X CRSR Corsair Gaming Secondary Managers: Goldman Sachs, Barclays, Credit Suisse, Macquarie, Baird, Cowen & Stifel, Wedbush, Academy Securities Priced at: $35.00 7.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DCBO X DCBO Docebo Secondary Managers: Morgan Stanley, Goldman Sachs & Canaccord Priced at: $49.67 2.013M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NVTA X NVTA Invitae Secondary Managers: JPMorgan, Morgan Stanley, Cowen & SVB Leerink Priced at: $51.50 7.77M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan Priced at: $22.00 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SI X SI Silvergate Capital Secondary Managers: Goldman Sachs, Keefe Bruyette & Canaccord, Compass Point, Craig-Hallum Priced at: $63.00 3.968M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACB X ACB Aurora Cannabis Spot Secondary Managers: BMO Capital, ATB Capital Markets Priced at: $10.45 12M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GSL X GSL Global Ship Lease Spot Secondary Managers: Jefferies & B. Riley Securities Priced at: $13.00 5.384M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PGEN X PGEN Precigen Spot Secondary Managers: Wells Fargo & Stifel, JMP Securities, H.C. Wainwright Priced at: $7.50 15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SENS X SENS Senseonics Spot Secondary Managers: H.C. Wainwright Priced at: $1.925 51.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Douglas Dynamics participates in a conference call with Craig-Hallum

TODAY'S FREE FLY STORIES

Get Full Fly Access